Cardinal Health (CAH) Aktie Kurs
Cardinal Health Kurs
De seneste 19 år voksede Cardinal Healths omsætning med 5,8 % årligt og nåede 254,25 Mrd. USD. Indtjening pr. aktie er vokset med 1,7 % om året de seneste 19 år. For Cardinal Health er nettoavance på 0,7 % op i forhold til -0,5 % for et par år siden. Ved dagens kurs bliver direkteafkastet cirka 0,55 %. Udlodningsandelen er omkring 74 % af indtjeningen. Udbyttet er vokset med 6,7 % om året de seneste 19 år. Konsensus 12-måneders kursmål for Cardinal Health er 290,00 USD, cirka over kursen med 4,3 %. Af 22 analytikere anbefaler 19 køb — den samlede vurdering er Køb.
Cardinal Health aktiekurs
Hent disse data via Eulerpool API
100.000 requests/md. gratis · intet kreditkort
Cardinal Health aktie og aktieanalyse
Hyppigt stillede spørgsmål om Cardinal Health-aktien
The business model of Cardinal Health Inc. revolves around providing essential services and solutions to healthcare organizations. As a renowned healthcare services and products company, Cardinal Health operates through various segments, including Pharmaceutical and Medical segments. The company distributes pharmaceuticals, medical and surgical products, along with offering innovative solutions and cost-effective services to healthcare providers. Cardinal Health also focuses on improving the efficiency and effectiveness of healthcare delivery, ultimately benefiting patients and healthcare professionals worldwide. With its extensive network and strong partnerships, Cardinal Health continues to excel in the healthcare industry and contribute to the overall well-being of communities.
Cardinal Health Inc is primarily active in the healthcare industry.
The main competitors of Cardinal Health Inc in the market include McKesson Corporation, AmerisourceBergen Corporation, and Owens & Minor Inc.
Cardinal Health Inc is a leading healthcare services and products company with a rich history and remarkable background. Established in 1971 in Dublin, Ohio, Cardinal Health initially focused on distributing pharmaceuticals to retail pharmacies. Over the years, it expanded its operations and services to include medical products, surgical supplies, and innovative healthcare technologies. Cardinal Health has gained extensive expertise in pharmaceutical sourcing, inventory management, and logistics, becoming a trusted partner in the healthcare industry. Today, it serves a diverse range of customers, including hospitals, pharmacies, clinics, and home healthcare providers. With its commitment to improving patient care and enhancing operational efficiency, Cardinal Health has established an impressive reputation within the healthcare sector.
Cardinal Health Inc has achieved several significant milestones throughout its history. One of its notable achievements includes being ranked #14 on the Fortune 500 list in 2020. The company has also been consistently recognized for its dedication to community involvement and sustainability efforts. In terms of its financial performance, Cardinal Health Inc has demonstrated consistent growth and profitability over the years. Moreover, the company has made strategic acquisitions and partnerships to expand its healthcare offerings and global reach. These milestones reflect Cardinal Health Inc's commitment to delivering innovative solutions and maintaining its position as a leader in the healthcare industry.
Cardinal Health Inc primarily operates in the United States.
Cardinal Health Inc represents values of integrity, excellence, and accountability in the healthcare industry. The company focuses on providing innovative solutions, quality products, and reliable services to meet the evolving needs of healthcare providers and patients. With a commitment to ethical business practices and corporate responsibility, Cardinal Health strives to improve the delivery of healthcare outcomes and enhance the overall well-being of communities. By fostering strong partnerships and embracing a patient-centric approach, Cardinal Health aims to drive positive change and improve the efficiency of healthcare operations.
Analytikere sætter i øjeblikket et gennemsnitligt kursmål på 288,27 USD for Cardinal Health-aktien (median: 290,00 USD), svarende til +3,7 % i forhold til seneste kurs. Konsensus bygger på 22 analytikervurderinger.
22 analytikere vurderer i øjeblikket Cardinal Health-aktien: 19 anbefaler køb, 3 hold og 0 salg.
Omregnet til den aktuelle valutakurs handles Cardinal Health-aktien til 253,26 EUR (277,93 USD).
Cardinal Health-aktien (CAH) er noteret på 7 børser, herunder: NYSE (CAH), London (0HTG.L), SIX (Zürich) (CLH.SW), Frankfurt (CLH.F), München (CLH.MU), Düsseldorf (CLH.DU).
The company Cardinal Health Inc is a pharmaceutical company that offers a wide range of services and products. The company is one of the leading healthcare providers worldwide and specializes in the areas of pharmacy, medical technology, and diagnostics. The company is particularly known for its pharmaceutical distribution services. Cardinal Health Inc supplies hospitals, pharmacies, and other healthcare facilities worldwide with pharmaceutical products. Additionally, the company also offers logistics and consulting services in the pharmaceutical industry. This includes support in the development and registration of pharmaceutical active ingredients as well as compliance consulting. Another pillar of the company is the development and manufacturing of medical products. Cardinal Health Inc offers a wide range of medical products, including consumables for medical applications and special medical technology. This includes devices for surgical procedures, diagnostic systems, and imaging systems. Another sector of Cardinal Health Inc is diagnostics. Under this area, the company offers a wide range of tests and analyses for medical facilities. This includes tests for cancer diagnostics, infection diagnostics, as well as determining genetic markers. The company places a strong emphasis on research and development. Cardinal Health Inc invests millions of dollars annually in the research and development of new products, as well as the improvement and optimization of existing products. The goal is always to offer customers innovative and future-oriented products. Another focus of the company is sustainability. Cardinal Health Inc aims to integrate sustainability and environmental protection into its daily business operations and to offer products and services that are not only economically but also environmentally and socially sustainable. Overall, Cardinal Health Inc offers a wide range of products and services for the pharmaceutical and medical industry. The different sectors complement each other optimally and enable the company to offer a comprehensive range. However, the company will continue to evolve and respond to the needs of customers in order to remain successful in the future.
-omsætningen for Cardinal Health er 254,25 Mrd. USD. Dette tal er baseret på aktuelle finansielle data og afspejler virksomhedens forretningsydeevne.
-overskuddet for Cardinal Health er 1,71 Mrd. USD. Nettooverskuddet afspejler virksomhedens rentabilitet efter fradrag af alle udgifter.
Pris-til-indtjening-forholdet (P/E) for Cardinal Health er i øjeblikket 37,78. P/E-forholdet sammenligner den nuværende aktiekurs med indtjeningen pr. aktie og hjælper investorer med at vurdere værdiansættelsen af Cardinal Health-aktien.
Pris-til-salgs-forholdet (P/S) for Cardinal Health er i øjeblikket 0,25. P/S-forholdet sammenligner markedskapitalisering med årlig omsætning og fungerer som en værdiansættelsesmetrik for Cardinal Health-aktien.
AlleAktien-kvalitetsscore for Cardinal Health er 5/10.
ISIN for Cardinal Health er US14149Y1082. ISIN (International Securities Identification Number) er en globalt unik identifikator for værdipapirer.
WKN for Cardinal Health er 880206. WKN (Wertpapierkennnummer) er et seks-cifret tysk identifikationsnummer for værdipapirer.
Tickeren for Cardinal Health er CAH. Tickersymbolet bruges til at handle Cardinal Health-aktier på børsen.
Cardinal Health aktie
Cardinal Health Peer Group
Cardinal Health Ticker
Cardinal Health FIGI
Alle fundamentale data om Cardinal Health i deep dive
Vores aktieanalyse af Cardinal Health-aktien indeholder vigtige finansielle nøgletal som omsætning, profit, P/E-ratioen, P/S-ratioen, EBIT samt informationer om udbytte. Desuden ser vi på aspekter som aktier, markedskapitalisering, gæld, egenkapital og forpligtelser hos Cardinal Health. Hvis du søger mere detaljerede oplysninger om disse emner, tilbyder vi på vores undersider omfattende analyser: